Compare Cassava Sciences Inc (FLNA) vs Hut 8 Corp (HUT) Price & Performance

FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.

Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.

HUT's stock is trading at $90.45, down 8.01% over the past 24 hours amid a bearish technical signal. The company reported a net loss of $226.15 million in 2025 despite revenue of $235.12 million, though recent earnings have shown volatility with a mix of beats and misses. Positive developments include a strategic pivot to AI infrastructure, securing $16.8 billion in contracted revenue, and strong analyst support with a 93.75% buy rating.

The outlook is a balance of high growth potential from its AI data center expansion against significant execution risks and persistent profitability challenges. The consensus price target of $138.89 implies substantial upside if the company successfully monetizes its infrastructure investments, but investors face risks from high debt levels, competitive pressures, and reliance on future project success.